{"id":529241,"date":"2021-02-08T13:48:01","date_gmt":"2021-02-08T13:48:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=529241"},"modified":"2021-02-08T13:48:01","modified_gmt":"2021-02-08T13:48:01","slug":"directtoconsumer-genetic-testing-market-manufacturers-research-methodology-competitive-landscape-and-business-opportunities-by-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/directtoconsumer-genetic-testing-market-manufacturers-research-methodology-competitive-landscape-and-business-opportunities-by-2027_529241.html","title":{"rendered":"Direct-to-Consumer Genetic Testing Market Manufacturers, Research Methodology, Competitive Landscape and Business Opportunities by 2027"},"content":{"rendered":"
Technological developments that allow predictive analytics are expected to increase demand for genetic testing directed to the customer. Also, the increasing prevalence of rare genetic disorders is expected to fuel the growth of the market for direct-to-consumer genetic testing.<\/div>\n

The global Direct-to-Consumer Genetic Testing Market is forecasted to reach USD 3.33 Billion by 2027, according to a new report by Emergen Research. Increasing genetic disease incidence would fuel competition for direct-to-consumer genetic testing and accelerate market development across the expected timeframe. Increasing cases of hereditary disorders such as breast cancer, achondroplasia, colorectal cancer and other diseases have increased the need for cost-effective and reliable avenues of genetic testing in the healthcare industry. For reference, according to the World Cancer Research Fund (WCRF), more than 2 million new cancer cases were reported globally in 2018. Breast cancer is now considered to be the second most prevalent disease. The introduction of a superior standard and innovative direct-to-consumer genetic testing has significantly lowered mortality levels of people with cancer by maintaining diligence surveillance data even before the onset of the disease. The preceding conditions would, therefore, accelerate the demand for direct-to-consumer genetic testing to reverse the timetable for the prediction.<\/p>\n

Get your Sample Copy with TOC of the Report to understand the structure of the complete report@ <\/strong>https:\/\/www.emergenresearch.com\/request-sample\/20<\/strong><\/a><\/p>\n

The prominent players of the global Direct-to-Consumer Genetic Testing market are expected to contribute significantly to the revenue generation owing to increasing demand for the Direct-to-Consumer Genetic Testing products in the industry.<\/p>\n

Key Players Participating in the Industry:<\/strong><\/p>\n

23andMe, Full Genome Corporation, Color Genomics, Genesis Healthcare, Helix OpCo LLC, FamilyTreeDNA, MyHeritage, Identigene, Pathway genomics, and Living DNA, among others.<\/p>\n

Furthermore, the report offers insights into the segmentation of the Direct-to-Consumer Genetic Testing industry based on product types, applications, end-user, technology, and key regions. The study also assesses the market segment expected to show significant growth in the coming years.<\/p>\n